Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-11 Sale | 2020-12-15 4:47 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) | View |
| 2020-06-26 Sale | 2020-06-30 7:17 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) | View |
| 2020-06-19 Sale | 2020-06-23 5:41 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-12 Other | 2021-03-16 8:20 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 5,259,492 | $0 | 7,220,655 (Indirect) | View |
| 2021-03-09 Gift | 2021-03-16 8:20 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 62,500 | $0 | 7,220,655 (Direct) | View |
| 2020-12-21 Other | 2020-12-23 6:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 383,411 | $0 | 12,585,045 (Indirect) | View |